Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Early or Progressing HAM/TSP
NCT00823641Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- Oct 2008
- Primary completion
- Mar 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of infliximab in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), sponsored by Imperial College London. Started Oct 2008; status: terminated.
02
Drugs
infliximab
03
Conditions
HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Beyond the preview
Go deeper on NCT00823641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00823641.